AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

oPen Versus RobotIc retrOmuscular Repair in Medium to Large Ventral Hernias

RecruitingNAAges 18 Years - anyAllUniversity Hospital, Basel, Switzerland
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This study investigates on the effect of two different operative techniques to treat large abdominal wall defects. The goal of this clinical trial is to learn if the minimally-invasive, robotically-assisted ventral hernia repair (RVHR) leads to a better outcome than the open ventral hernia repair (OVHR). The main questions it aims to answer are: length of stay after the operation rate of complications rate of recurrence and reoperations quality of life. Participants will: Either be operated using the RVHR or OVHR will be followed up either in person or via email / phone call at day 7, day 30, 6 months, 1, 3 and 5 years after the surgery to asses the above-stated main and some more outcomes.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Patient age \>18 years * Informed consent obtained * Transverse diameter of ventral hernia \>4cm - 15cm * Eligible to open and minimally-invasive surgery according to preoperative anaesthetic assessment Exclusion Criteria: * precedent hernia treatment with mesh placement in the retromuscular space * precedent anterior or posterior component separation or transversus abdominis release (TAR) * active wound infection * current cancer diagnosis * presence of ileostomy, colostomy or ileal conduit * liver disease defined by the presence of ascites * end-stage renal disease requiring dialysis * need of an emergency surgery * pregnancy Criteria for participating surgeons Each participating surgeon has performed 20 or more OVHR and RVHR.
๐Ÿ’Š

What it tests

  • Robotically-assisted ventral hernia repair (RVHR)
  • Open ventral hernia repair (OVHR)
๐Ÿ“

Where

3 sites
Klinikum Kempten
Kempten (Allgรคu), Germany
University Hospital Basel
Basel, Switzerland
Spital Oberwallis, Visp
Visp, Switzerland
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy